Evidence map›Paper›PMID 40297210›Full record

ArticleTherapeutic advances in gastroenterology2025

Comment on "Effectiveness and safety of oral vancomycin for the treatment of inflammatory bowel disease associated with primary sclerosing cholangitis: a systematic review and pooled analysis".

Richard Kellermayer, Peter Lewindon, Cynthia Buness, James Tabibian, Kevin Johnson, Shamita Shah, Parambir Dulai, Ahmad H Ali, Ayesha Shah, Gerald Holtmann and 1 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Therapeutic advances in gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Richard KellermayerDivision of Pediatric Gastroenterology, Department of Pediatrics, Texas Children's Hospital, Baylor College of Medicine, 6621 Fannin Street, Houston, TX 77030-3411, USA.ORCID https://orcid.org/0000-0002-4146-1335
Peter LewindonUniversity of Queensland, Brisbane, QLD, Australia.
Cynthia BunessGlobal Liver Institute Pediatric and Rare Liver Diseases Research Council, Washington, DC, USA.
James TabibianAdvanced Gastroenterology Center Adventist Health Glendale Medical Center, Glendale, CA, USA.
Kevin JohnsonDepartment of Radiology and Biomedical Imaging, Yale University, New Haven, CT, USA.
Shamita ShahDepartment of Gastroenterology, Ochsner Medical Center, New Orleans, LA, USA.
Parambir DulaiDivision of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID https://orcid.org/0000-0002-9514-2321
Ahmad H AliDivision of Gastroenterology and Hepatology, University of Missouri School of Medicine, Columbia, MO, USA.ORCID https://orcid.org/0000-0001-8553-7744
Ayesha ShahFaculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Gerald HoltmannFaculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Harland S WinterMass General Hospital for Children, Harvard Medical School, Boston, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

inflammatory bowel diseaseprimary sclerosing cholangitisulcerative colitisvancomycinvancomycin resistant enterococcus, VRE

Identifiers

PMID40297210
PMCPMC12035255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.